Divis Laboratories Ltd | DIVI - Cost Of Sales

Stock Price
6,905.50
Daily Change
70.50 1.03%
Monthly
9.96%
Yearly
7.02%
Q2 Forecast
6,615.83

Divis Laboratories Ltd reported INR10.63B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Aurobindo Pharma INR 39.46B 6.07B Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Lupin INR 22.98B 1.07B Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025